This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Sho Toyonaga
Director, Drug Delivery Research at FUJIFILM Pharmaceuticals U.S.A., Inc
Speaker

Profile

Sho Toyonaga, Ph.D. is the Director of Drug Delivery Research at FUJIFILM Pharmaceuticals U.S.A., Inc., where he leads research and early development of lipid nanoparticle (LNP) technology for nucleic acid delivery to extrahepatic tissues. Since 2019, he has also served as a Visiting Scientist in the Anderson Lab at MIT, where he leads efforts to develop targeted delivery systems for specific cell types, including hematopoietic stem cells.

Sho has extensive expertise in formulation development, pharmacokinetics, and immuno-oncology, as well as a strong foundation in structural biology gained during his B.S., M.S., and Ph.D. studies in the Department of Pharmaceutical Sciences at the University of Tokyo. His professional experience includes roles at FUJIFILM Corporation and the Koch Institute for Integrative Cancer Research at MIT.